Adhir Shroff, MD
Cardiovascular Disease · Chicago, ILNPI 1285672196
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 30.3% of the total. Reporting peaked in 2019 at $50,389 and has fallen 97.9% since, to $1,065 in 2025. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $448.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$33K
- Terumo Medical Corporation$17K
- Abbott$14K
- Cardiovascular Systems Inc.$13K
- Abiomed$11K
- Shockwave Medical, Inc$9K
- plus $14K from 21 others
Across 59 payments — averaging $2590.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$48K
- Medtronic$40K
- Amgen$27K
- Cardiovascular Systems Inc.$26K
- Biotronik Inc.$13K
What the payments were for
- Consulting fees$42,34938%
- Speaking & faculty fees$49,45945%
- Travel & lodging$11,97511%
- Food & beverage$6,8136%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 79 | $33,485 |
| Terumo Medical Corporation | 24 | $16,582 |
| Abbott | 25 | $13,685 |
| Cardiovascular Systems Inc. | 35 | $12,676 |
| Abiomed | 23 | $11,128 |
| Shockwave Medical, Inc | 12 | $9,177 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $6,557 |
| Cardinal Health 200 LLC | 4 | $2,529 |
| Merit Medical Systems Inc | 5 | $1,680 |
| ZOLL Circulation Inc | 1 | $1,350 |
| Biotronik Inc. | 12 | $586 |
| Inari Medical, Inc. | 2 | $315 |
| Stryker | 1 | $157 |
| Asahi Intecc USA, Inc. | 1 | $155 |
| Atricure, Inc. | 1 | $128 |
| Cardiva Medical, Inc. | 1 | $101 |
| Chiesi USA, Inc. | 1 | $62 |
| Surmodics, Inc. | 2 | $45 |
| AstraZeneca | 3 | $45 |
| Boston Scientific | 2 | $41 |
| Opsens Inc. | 1 | $37 |
| Penumbra, Inc. | 1 | $32 |
| Johnson & Johnson | 1 | $28 |
| Teleflex LLC | 1 | $27 |
| Edwards Lifesciences | 1 | $20 |
| Cordis US CORP. | 1 | $17 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$17,622
- TR Band$13,262
- Glidesheath$11,412
- Coronary Orbital Atherectomy System$11,087
- Optitorque$11,062
- Heartrail$11,062
- Impella$10,844
- Omnilink Elite vascular stent system$9,250
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$8,849
- LifeVest$6,500
- GLIDESHEATH SLENDER$4,050
- RESOLUTE ONYX$4,013
- GlideWire$3,650
- Perclose ProGlide suture mediated closure system$3,626
- TherOx DS2 Console$1,350
- Catheter$1,350
- Downstream Cartridge$1,350
- Diamondback Coronary$1,111
- TRAcelet$1,077
- RAILWAYTM$1,000
How this compares
$110,658 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 33 | $41,700 |
| Praluent PenAlirocumab | 59 | $27,831 |
| Repatha SureclickEvolocumab | 17 | $9,044 |
| Metoprolol Succinate | 28 | $640 |
| Atorvastatin Calcium | 42 | $345 |
| Losartan Potassium | 13 | $160 |
| Carvedilol | 13 | $86 |
| Lisinopril | 17 | $80 |
| Metoprolol Tartrate | 12 | $79 |
| Amlodipine Besylate | 14 | $77 |
| Furosemide | 20 | $67 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.